The culmination of those mentioned milestones and goal is approval from the regulating authority. All the intrinsic value of this companies IP is validated upon approval of the MAA by the MHRA.
To essentially say, “because the market reacted to events A, B, and C in such a way then the market will react similarly to event D.” is such a falsehood.
Did you just refer to Europe as one small jurisdiction?